US37611X1000
© PR Newswire
22.12.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach
News Preview
BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Carnegie-Mellon University (CMU) for an award by the Advanced Research Projects Agency for Health (ARPA-H) for its POSEIDON program (Platform Optimizing SynBio for Early Intervention and Detection in Oncology). With Ginkgo Bioworks serving as the...
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2025
DNA
LISTED
NYSE
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
News Preview
Collaboration reduces time in fermenting complex bacterial strains, enabling continued focus on next-gen biological crop solutions.BOSTON and PLANO, Texas, Dec. 17, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo"), a provider of research and development services and tools for biological product development and Agricen, a leader in the de...
Themefolio
Profiler
Peergroup
© PR Newswire
09.12.2025
DNA
LISTED
NYSE
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety
News Preview
BOSTON, Dec. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Deep Origin on a 4.5-year project funded by the Advanced Research Projects Agency for Health (ARPA-H) Computational ADME-Tox and Physiology Analysis for Safer Therapeutics (CATALYST) program. CATALYST is led by ARPA-H Health Science Futures Missio...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© PR Newswire
05.12.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC
News Preview
BOSTON, Dec. 5, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has been awarded by the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Laboratory (PNNL) a four-year, up to $47M contract to co-design, build, and integrate a High‑Throughput Automated Phenotyping Platform (HTP‑APP) in support of t...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
03.12.2025
DNA
LISTED
NYSE
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy
News Preview
CAMBRIDGE, Mass., Dec. 3, 2025 /PRNewswire/ -- STRM.BIO, a start-up biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced that it has been awarded a contract from the Advanced Research Projects Agency for Health (ARPA-H) through its Engineering of Immune Cells Inside the Body (EMBODY) p...
Themefolio
Profiler
Peergroup
© PR Newswire
18.11.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health
News Preview
BOSTON, Nov. 18, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on a five-year initiative funded by the Advanced Research Projects Agency for Health (ARPA-H). The collaboration, Microbe/phage In...
Themefolio
Profiler
Peergroup
© PR Newswire
06.11.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results
News Preview
Ginkgo provides an update on its third quarter financial results
BOSTON, Nov. 6, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced its results for the third quarter ended September 30, 2025. The update, including a webcast...
Themefolio
Profiler
Peergroup
© PR Newswire
03.11.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium
News Preview
Ginkgo and Partners to Develop Monoclonal Antibody Biomanufacturing Innovations and to Produce an Anti-Filovirus Medical Countermeasure
BOSTON, Nov. 3, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that it has been awarded a contract through t...
Themefolio
Profiler
Peergroup
© PR Newswire
31.10.2025
DNA
LISTED
NYSE
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture
News Preview
BOSTON, Oct. 31, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that the company has extended its multi-year strategic partnership with Bayer to advance research and development of biological products for agriculture. With the extension of this partnership, which began in 2017, both parties will...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results Presentation
News Preview
Presentation and Q&A session scheduled for post-market on Thursday, November 6, 2025
BOSTON, Oct. 30, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo") today announced that it plans to host a presentation and Q&A session reviewing...
Themefolio
Profiler
Peergroup
© PR Newswire
23.10.2025
DNA
LISTED
NYSE
Ginkgo Bioworks in Partnership with STRM.BIO and University of British Columbia in Project to Develop In Vivo CAR Therapies Under ARPA-H's EMBODY Program
News Preview
Ginkgo Bioworks to apply its RNA construct design expertise to develop long-lived, tissue-specific, and highly potent in vivo CAR therapies for autoimmune diseases
BOSTON, Oct. 23, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced a collaboration with STRM.BIO and...
Themefolio
Profiler
Peergroup
© BusinessWire
04.09.2025
DNA
LISTED
NYSE
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium
News Preview
Ginkgo Bioworks (NYSE: DNA) today announced a series of new initiatives from its Datapoints offering to accelerate the application of artificial intelligence in biologics drug discovery. These include a strategic partnership with Apheris to launch the Antibody Developability Consortium and, separately, the AbDev AI Competition. Together, these eff...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© PR Newswire
29.08.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions
News Preview
BOSTON, Aug. 29, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today released the following notice:
UNITED STATES DISTRICT COURTNORTHERN DISTRICT OF CALIFORNIAOAKLAND DIVISION
WEINING HU, derivatively on behalf of GINKGO BIOWORK...
Themefolio
Profiler
Peergroup
© PR Newswire
20.08.2025
DNA
LISTED
NYSE
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry
News Preview
BOSTON, Aug. 20, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that its Datapoints offering has entered into a new strategic partnership with Inductive Bio and Tangible Scientific to make AI-driven lab-in-the-loop drug discovery broadly accessible acr...
Themefolio
Profiler
Peergroup
© PR Newswire
12.08.2025
DNA
LISTED
NYSE
Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth
News Preview
Seasoned life‑science executive to spearhead global go‑to‑market strategy as Ginkgo Automation scales external sales across biopharma, techbio, and new science‑driven markets while continuing to support internal programs.
BOSTON, Aug. 12, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming...
Themefolio
Profiler
Peergroup
© PR Newswire
07.08.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Reports Second Quarter 2025 Financial Results
News Preview
Ginkgo provides an update on its restructuring, including achievement of its expanded $250 million cost savings targets
BOSTON, Aug. 7, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the second quarter ended Jun...
Themefolio
Profiler
Peergroup
© PR Newswire
30.07.2025
DNA
LISTED
NYSE
Ginkgo to Deploy Modular Automation Technology to the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Labs (PNNL) to Accelerate Microbial Research for the Bioeconomy
News Preview
Ginkgo will build a platform driven by its Reconfigurable Automation Carts (RACs) technology to enable EMSL's open-ended exploration of bioconomy-relevant microbes
BOSTON, July 30, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that the Environmental M...
Themefolio
Profiler
Peergroup
© PR Newswire
17.07.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Launches ADME Profiling Service Using Lab Automation, Offering a US-based Operation That Will Match or Beat Pricing Quotes from Chinese or Other International Vendors
News Preview
Ginkgo Bioworks launches cost-effective, high-throughput ADME profiling service to accelerate small molecule drug discovery with model-ready datasets
BOSTON, July 17, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the launch of a powerful new capabilit...
Themefolio
Profiler
Peergroup
© PR Newswire
21.05.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer
News Preview
BOSTON, May 21, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity, today announced that Mark Dmytruk, the Company's Chief Financial Officer, intends to resign from his role at the Company on May 30, 2025 to accept a position at another organizat...
Themefolio
Profiler
Peergroup
© PR Newswire
06.05.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Reports First Quarter 2025 Financial Results
News Preview
Ginkgo provides an update on its restructuring, including progress towards its expanded $250 million cost savings target
Ginkgo and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems
BOSTON, May 6, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings,...
Themefolio
Profiler
Peergroup
© PR Newswire
30.04.2025
DNA
LISTED
NYSE
Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors
News Preview
Replacing artificial dyes with natural colors has become a national priority, moved by consumer demand, regulation, and governmental pressure.Achieving this milestone—by increasing coloring efficiency and reducing costs—could unlock new market segments that are not well-supported by current natural food colors.The achievement grants Ginkgo with a...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation
News Preview
Presentation and Q&A session scheduled for post-market on Tuesday, May 6, 2025
BOSTON, April 29, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business p...
Themefolio
Profiler
Peergroup
© PR Newswire
22.04.2025
DNA
LISTED
NYSE
Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation
News Preview
BOSTON, April 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Ginkgo Automation will design and deploy a Reconfigurable Automation Cart (RAC) system to Aura Genetics, a high-complexity diagnostic laboratory servicing the growing at-home testi...
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain
News Preview
Ginkgo Bioworks and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems
BOSTON, April 10, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a new contrac...
Themefolio
Profiler
Peergroup
© PR Newswire
25.02.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Reports Fourth Quarter and Full Year 2024 Financial Results
News Preview
Ginkgo provides update on its restructuring process including significant improvement in cash flow in the fourth quarter, completion of site consolidation and an expanded cost savings target
Cell Engineering revenue of $35 million in the fourth quarter of 2024, representing 29% growth over 2023
BOSTON, Feb. 25, 2025 /PRNewswire/ -- Ginkgo Biowork...
Themefolio
Profiler
Peergroup
© PR Newswire
21.02.2025
DNA
LISTED
NYSE
Ginkgo Bioworks integrates Callisto for difficult-to-automate NGS processes in their high-throughput lab
News Preview
BOSTON, Feb. 21, 2025 /PRNewswire/ -- Volta Labs, a leading genomics applications company, and Ginkgo Bioworks, (NYSE: DNA), which is building a leading platform for cell programming and biosecurity, today announced the integration of the Callisto™ Sample Prep System at Ginkgo Bioworks as part of the routine Illumina sequencing workflow....
Themefolio
Profiler
Peergroup
© PR Newswire
20.02.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care
News Preview
International consortium to develop rapid metagenomic NGS solutions that can identify known and novel respiratory pathogens, reduce time-to-diagnosis, and enhance hospital decision-making and public health preparedness
BOSTON, Feb. 20, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming an...
Themefolio
Profiler
Peergroup
© PR Newswire
18.02.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2024 Results Presentation
News Preview
Presentation and Q&A session scheduled for post-market on Tuesday, February 25, 2025
BOSTON, Feb. 18, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) ("Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing busi...
Themefolio
Profiler
Peergroup
© PR Newswire
06.02.2025
DNA
LISTED
NYSE
Ginkgo Bioworks to Host 6th Annual Ferment as Boston-based Conference Series
News Preview
Evolution of Ferment conference to kick off Summer 2025
BOSTON, Feb. 6, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the 2025 Ferment Series, an evolution of its flagship annual conference dedicated to advancing Ginkgo's mission of making biology...
Themefolio
Profiler
Peergroup
© PR Newswire
23.01.2025
DNA
LISTED
NYSE
Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)
News Preview
Customizable, anaerobic-enabled system aims to accelerate discovery and development of sustainable biofuels at the University of Wisconsin–Madison's GLBRC
BOSTON, Jan. 23, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Ginkgo Automation will desig...
Themefolio
Profiler
Peergroup
© PR Newswire
13.01.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors
News Preview
Collaboration leverages Ginkgo's cell engineering and screening platform to enhance the potency and persistence of Universal Cells' iPSC-derived immune cell therapeutics
BOSTON, Jan. 13, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a research collabo...
Themefolio
Profiler
Peergroup
© PR Newswire
09.01.2025
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
News Preview
BOSTON, Jan. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Co-Founder and CEO, Jason Kelly, is scheduled to present at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. PT (1:30 p.m. ET)....
Themefolio
Profiler
Peergroup
© PR Newswire
17.12.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program
News Preview
Ginkgo Bioworks to apply its mammalian cell engineering expertise to develop new cell-based systems for treating and monitoring endocrine disorders
BOSTON, Dec. 17, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a subcontract of up to $9.4 million awar...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
News Preview
Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions
Ginkgo signs new and expanded deals with Novo Nordisk and achieves a major research milestone with Merck
BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkg...
Themefolio
Profiler
Peergroup
© PR Newswire
12.11.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
News Preview
BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the completion of the first milestone of a previously announced partnership with Merck, known as MSD outside of the United States and Canada, focused on improving biologic manufacturing. A...
Themefolio
Profiler
Peergroup
© PR Newswire
05.11.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation
News Preview
Presentation and Q&A session scheduled for post-market on Tuesday, November 12, 2024
BOSTON, Nov. 5, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing busine...
Themefolio
Profiler
Peergroup
© PR Newswire
24.09.2024
DNA
LISTED
NYSE
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
News Preview
BOSTON and CHESTERFIELD, Mo., Sept. 24, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced its new partnership with NOVUS International, an innovator and leader in intelligent nutrition, to develop advanced feed additives designed to meet the evolving nee...
Themefolio
Profiler
Peergroup
© PR Newswire
18.09.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
News Preview
BOSTON, Sept. 18, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, proudly announces the launch of Ginkgo Datapoints to usher in the next era of biotechnology by making the training of AI models easier and more efficient. Ginkgo Datapoints is specialized in gener...
Themefolio
Profiler
Peergroup
© PR Newswire
17.09.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
News Preview
Protein large language model (LLM) designed to help enterprises accelerate drug development coming to Google Cloud's Vertex AI Model Garden soon; one of the first-of-its-kind in the industry
Model API programmable interface now available for individual scientists and researchers to quickly test and advance work
BOSTON, Sept. 17, 2024 /PRNewsw...
Themefolio
Profiler
Peergroup
© PR Newswire
04.09.2024
DNA
LISTED
NYSE
Ginkgo Regains Compliance with NYSE Minimum Bid Price Requirement
News Preview
BOSTON, Sept. 4, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity, today announced that it had received a letter from the New York Stock Exchange ("NYSE") on September 3, 2024 stating that because Ginkgo's Class A common stock ha...
Themefolio
Profiler
Peergroup
© PR Newswire
30.08.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
News Preview
BOSTON, Aug. 30, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Chief Financial Officer, Mark Dmytruk, is scheduled to participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Friday, Septembe...
Themefolio
Profiler
Peergroup
© PR Newswire
08.08.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Reports Second Quarter 2024 Financial Results
News Preview
Ginkgo provides update on its restructuring process including estimated annualized cost savings of over $85 million from reduction in force
BOSTON, Aug. 8, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the sec...
Themefolio
Profiler
Peergroup
© PR Newswire
02.08.2024
DNA
LISTED
NYSE
Ginkgo Bioworks to Hold Special Meeting of Shareholders
News Preview
Special meeting to take place virtually on August 14, 2024 at 4:00 pm ET
BOSTON, Aug. 2, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, will be holding a special meeting of shareholders virtually on August 14, 2024 at 4:00 pm ET to vote to per...
Themefolio
Profiler
Peergroup
© PR Newswire
01.08.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Presentation
News Preview
Presentation and Q&A session scheduled for post-market on Thursday, August 8, 2024
BOSTON, Aug. 1, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business...
Themefolio
Profiler
Peergroup
© PR Newswire
16.07.2024
DNA
LISTED
NYSE
Syngenta collaborates with Ginkgo Bioworks to enable faster launch of innovative biologicals
News Preview
Syngenta will leverage Ginkgo's Ag Biologicals capabilities to optimize secondary metabolite production for a pioneering biological solution
BASEL, Switzerland and BOSTON, July 16, 2024 /PRNewswire/ -- Syngenta Crop Protection, a leader in agricultural innovation, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell p...
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2024
DNA
LISTED
NYSE
Ginkgo Bioworks to Participate in Two Conferences in May
News Preview
BOSTON, May 15, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that management will be participating in two investor conferences in May....
Themefolio
Profiler
Peergroup
© PR Newswire
15.05.2024
DNA
LISTED
NYSE
Sojitz Corporation and Ginkgo Bioworks Announce Plans to Use Synthetic Biology R&D Services to Accelerate Sustainable Manufacturing in Japan
News Preview
Sojitz intends to use its extensive network to help Ginkgo foster business connections within the Japanese bioeconomy
TOKYO and BOSTON, May 14, 2024 /PRNewswire/ -- Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for ce...
Themefolio
Profiler
Peergroup
© PR Newswire
13.05.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Receives Continued Listing Standard Notice From NYSE
News Preview
Ginkgo's Class A Common Stock continues to trade on the NYSE
BOSTON, May 13, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity, today announced that it received a notice on May 7, 2024 from the New York Stock Exchange ("NYSE") inf...
Themefolio
Profiler
Peergroup
© PR Newswire
09.05.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Reports First Quarter 2024 Financial Results
News Preview
Ginkgo announces several initiatives to accelerate path to Adjusted EBITDA breakeven by end of 2026
Initiatives include a reduction of $200 million in annualized run-rate operating expenses by mid-2025, with anticipated substantial reduction occurring in 2024
BOSTON, May 9, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo")...
Themefolio
Profiler
Peergroup
© PR Newswire
07.05.2024
DNA
LISTED
NYSE
GreenLab Partners with Ginkgo Bioworks to Scale Up Production of Brazzein, a Novel Sweetener
News Preview
To scale up its production of brazzein, GreenLab will leverage its proprietary technology to grow proteins inside corn kernels, optimizing its process with Ginkgo's Plant Trait Services, Protein Services, and Deployment Capabilities
JONESBORO, Ark. and BOSTON, May 7, 2024 /PRNewswire/ -- GreenLab, an emerging next generation plant-biotechnolo...
Themefolio
Profiler
Peergroup
© PR Newswire
06.05.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Presentations at the Upcoming American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
News Preview
BOSTON, May 6, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced its participation in the 27th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, May 7-11, in Baltimore, MD. Ginkgo will present three posters in cell therapy and give one o...
Themefolio
Profiler
Peergroup
© PR Newswire
02.05.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Date of First Quarter 2024 Results Presentation
News Preview
Presentation and Q&A session scheduled for post-market on Thursday, May 9, 2024
BOSTON, May 2, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and Q&A session reviewing business per...
Themefolio
Profiler
Peergroup
© PR Newswire
29.04.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Nomination of Myrtle Potter and Ross Fubini to Board of Directors
News Preview
BOSTON, April 29, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the nomination of Myrtle Potter and Ross Fubini for election as independent directors at Ginkgo's upcoming annual meeting, scheduled to be held on June 13, 2024....
Themefolio
Profiler
Peergroup
© PR Newswire
16.04.2024
DNA
LISTED
NYSE
Il Granaio delle Idee and Ginkgo Bioworks Announce Strategic Collaboration to Optimize Sourdough Strains for Bakery Products
News Preview
IGDI will leverage Ginkgo's Adaptive Laboratory Evolution technology to improve its sourdough starter culture product
PADUA, Italy and BOSTON, April 16, 2024 /PRNewswire/ -- Il Granaio delle Idee (IGDI), an innovative international developer and provider of clean label baking ingredients, and Ginkgo Bioworks (NYSE: DNA), which is building the lea...
Themefolio
Profiler
Peergroup
© PR Newswire
11.04.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Previews Today's Annual Ferment Conference, Announces "Lab Data as a Service"
News Preview
BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its 5th annual Ferment conference. The conference brings together stakeholders from across the synthetic biology community, including R&D leaders, Ginkgo Technology Network partners...
Themefolio
Profiler
Peergroup
© PR Newswire
11.04.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Announces Acquisition of AgBiome's Platform Assets
News Preview
BOSTON, April 11, 2024 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of AgBiome's platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metada...
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2024
DNA
LISTED
NYSE
Ginkgo Bioworks and Novo Nordisk Expand Alliance to Collaborate Across R&D Value Chain
News Preview
BOSTON, April 10, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is developing the leading platform for cell programming and biosecurity, today announced the expansion of its strategic partnership with global healthcare leader Novo Nordisk under a framework agreement that initially is contemplated to run over five years. ...
Themefolio
Profiler
Peergroup
© PR Newswire
10.04.2024
DNA
LISTED
NYSE
Ginkgo Bioworks Awarded Grant for AI-enabled Forecasting of Measles Outbreaks
News Preview
Ginkgo epidemiological modeling experts and Northeastern University researchers awarded new grant from the Bill & Melinda Gates Foundation
BOSTON, April 10, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that it has been awarded a grant from the Bi...
Themefolio
Profiler
Peergroup
© PR Newswire
08.04.2024
DNA
LISTED
NYSE
IdeeLab Joins the Ginkgo Technology Network to Provide Agriculture Companies in Brazil with End-to-End Product Development & Manufacturing Service
News Preview
Ginkgo customers will now have access to IdeeLab's local strain discovery capabilities, as well as the ability to manufacture next-generation products in IdeeLab's manufacturing facilities
PIRACICABA, Brazil, April 8, 2024 /PRNewswire/ -- IdeeLab Biotechnology, a Brazilian company aiming to develop innovations and biological solutions for agricul...
Themefolio
Profiler
Peergroup
© PR Newswire
04.04.2024
DNA
LISTED
NYSE
Ginkgo Bioworks to Host 5th Annual Ferment Conference
News Preview
BOSTON, April 4, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, is hosting its annual conference, Ferment, on Thursday, April 11, 2024 in Boston, MA. The conference brings together stakeholders from across the synthetic biology ecosystem and the Ginkgo community, from...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
